These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 2076342

  • 1. [Transdermal therapeutic system of scopolamine (TTS-S) in the prevention of sea sickness and its mechanism of action].
    Wang E.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Oct; 25(5):299-302, 319. PubMed ID: 2076342
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Histaminergic response to Coriolis stimulation: implication for transdermal scopolamine therapy of motion sickness.
    Wang ET, Zhou DR, He LH.
    Aviat Space Environ Med; 1992 Jul; 63(7):579-82. PubMed ID: 1616432
    [Abstract] [Full Text] [Related]

  • 4. [Prevention of motion sickness with a transdermal therapeutic system containing scopolamine. A randomized, comparative double-blind study in the German Federal Navy].
    Becker G, Goossens H, Seemann K, Souchon F, Weitz T.
    Dtsch Med Wochenschr; 1984 Dec 07; 109(49):1881-5. PubMed ID: 6499689
    [Abstract] [Full Text] [Related]

  • 5. Influence of transdermal scopolamine on motion sickness during 7 days' exposure to heavy seas.
    van Marion WF, Bongaerts MC, Christiaanse JC, Hofkamp HG, van Ouwerkerk W.
    Clin Pharmacol Ther; 1985 Sep 07; 38(3):301-5. PubMed ID: 4028625
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Study on effect of acupoint sticker of TTS-ST93-1 in treating motion sickness].
    Pei J, Yang T, Liu Z.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Aug 07; 18(8):464-7. PubMed ID: 11477828
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
    Noy S, Shapira S, Zilbiger A, Ribak J.
    Aviat Space Environ Med; 1984 Nov 07; 55(11):1051-4. PubMed ID: 6508687
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Comparative in-flight study of a scopolamine-containing membrane plaster versus dimenhydrinate under defined acceleration conditions].
    Offenloch K, Zahner G, Dietlein G, Franz I.
    Arzneimittelforschung; 1986 Sep 07; 36(9):1401-6. PubMed ID: 3539128
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Prevention of kinetosis in children. Transdermal therapy with scopolamine].
    Müller M, Besch W, Steilner D.
    Fortschr Med; 1987 Feb 10; 105(4):82, 86-7. PubMed ID: 3557264
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.